Calithera Biosciences Inc (CALA)
0.0250
-0.01
(-37.38%)
USD |
OTCM |
Apr 18, 16:00
Calithera Biosciences Cash from Operations (TTM): -43.61M for Dec. 31, 2022
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2022 | -43.61M |
September 30, 2022 | -60.58M |
June 30, 2022 | -60.45M |
March 31, 2022 | -60.31M |
December 31, 2021 | -66.30M |
September 30, 2021 | -63.73M |
June 30, 2021 | -72.42M |
March 31, 2021 | -79.30M |
December 31, 2020 | -84.31M |
September 30, 2020 | -79.71M |
June 30, 2020 | -83.08M |
March 31, 2020 | -85.14M |
December 31, 2019 | -78.74M |
September 30, 2019 | -74.24M |
June 30, 2019 | -71.12M |
March 31, 2019 | -70.51M |
December 31, 2018 | -64.84M |
Date | Value |
---|---|
September 30, 2018 | -62.32M |
June 30, 2018 | -57.06M |
March 31, 2018 | -36.45M |
December 31, 2017 | 13.75M |
September 30, 2017 | 16.34M |
June 30, 2017 | 20.64M |
March 31, 2017 | 11.83M |
December 31, 2016 | -31.02M |
September 30, 2016 | -32.17M |
June 30, 2016 | -31.55M |
March 31, 2016 | -29.91M |
December 31, 2015 | -29.93M |
September 30, 2015 | -24.49M |
June 30, 2015 | -23.76M |
March 31, 2015 | -22.34M |
December 31, 2014 | -19.23M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-85.14M
Minimum
Mar 2020
-43.61M
Maximum
Dec 2022
-70.87M
Average
-72.42M
Median
Jun 2021
Cash from Operations (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | -4.131M |
Palatin Technologies Inc | -26.54M |
iBio Inc | -18.89M |
Theriva Biologics Inc | -19.00M |
Ampio Pharmaceuticals Inc | -8.564M |